SPONSOR
Shanghai Bovax Biotechnology Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
Conditions studied: HPV InfectionHPV-Related CarcinomaHPV-Related Intraepithelial NeoplasiaGenital WartCervical CancerVulvar CancerVaginal CancerCIN1CIN2CIN3
Shanghai Bovax Biotechnology Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including HPV Infection, HPV-Related Carcinoma, HPV-Related Intraepithelial Neoplasia, Genital Wart.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Bovax Biotechnology Co., Ltd.
How many clinical trials has Shanghai Bovax Biotechnology Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shanghai Bovax Biotechnology Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including HPV Infection, HPV-Related Carcinoma, HPV-Related Intraepithelial Neoplasia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Bovax Biotechnology Co., Ltd. research focus on?
Shanghai Bovax Biotechnology Co., Ltd. clinical trials span HPV Infection, HPV-Related Carcinoma, HPV-Related Intraepithelial Neoplasia, Genital Wart, Cervical Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Bovax Biotechnology Co., Ltd. clinical trial?
To participate in a Shanghai Bovax Biotechnology Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Bovax Biotechnology Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai Bovax Biotechnology Co., Ltd.
NCT06756269 Phase 2
Recruiting
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
HPV Infection
NCT04422366 Phase 3
Recruiting
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Cervical Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology